The Board of Directors of the Company at its meeting held today i.e. Wednesday , August 13, 2025 at Registered Office of the Company has inter alia considered and approved the Un-audited Standalone and Consolidated Financial Results along with Limited Review Report of the Company for the Quarter ended on 30th June, 2025.
Board Meeting Outcome for Board Meeting Outcome
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Vivanza Biosciences Ltd. on 6ix
Earlier from Vivanza Biosciences
- Vivanza Biosciences Ltd. Press Release Aug 08 2025
- Board Meeting Intimation for Consideration And Approved The Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June, 2025.
- Vivanza Biosciences Ltd. Press Release Jul 14 2025
- Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Later from Vivanza Biosciences
- Financial Results For 30Th June, 2025
- Vivanza Biosciences Ltd. Press Release Aug 13 2025
- Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1)(A) And Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- 43Rd AGM Related Agendas.
- Vivanza Biosciences Ltd. Press Release Aug 28 2025
Follow Vivanza Biosciences into a list and get an email when it puts out news.
Follow Vivanza Biosciences